Figure 3.
Overall survival according to treatment in non-metastatic patients. The median overall survival was 17.8 ± 1.5 months for patients with curative treatment and 5.5 ± 2.0 months for patients with best supportive care (BSC).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.